These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9846034

  • 1. Treatment of depression in HIV-infected patients.
    Cazzullo CL, Bessone E, Bertrando P, Pedrazzoli L, Cusini M.
    J Psychiatry Neurosci; 1998 Nov; 23(5):293-7. PubMed ID: 9846034
    [Abstract] [Full Text] [Related]

  • 2. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
    Rabkin JG, Rabkin R, Wagner G.
    J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
    [Abstract] [Full Text] [Related]

  • 3. Antidepressant treatment of depression in HIV-seropositive women.
    Ferrando SJ, Rabkin JG, de Moore GM, Rabkin R.
    J Clin Psychiatry; 1999 Nov; 60(11):741-6. PubMed ID: 10584761
    [Abstract] [Full Text] [Related]

  • 4. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 5. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.
    Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036
    [Abstract] [Full Text] [Related]

  • 6. Major depressive subtypes and treatment response.
    Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF.
    Biol Psychiatry; 1997 Oct 01; 42(7):568-76. PubMed ID: 9376453
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of paroxetine for the treatment of depression in the context of HIV infection.
    Grassi B, Gambini O, Garghentini G, Lazzarin A, Scarone S.
    Pharmacopsychiatry; 1997 Mar 01; 30(2):70-1. PubMed ID: 9131727
    [Abstract] [Full Text] [Related]

  • 9. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM, Kluge M, Maras A, Riemann D, Berger M, Kohnen R, Dittmann RW, Gattaz WF.
    Pharmacopsychiatry; 2005 Jan 01; 38(1):13-6. PubMed ID: 15706460
    [Abstract] [Full Text] [Related]

  • 10. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U, Onder E.
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec 01; 253(6):307-12. PubMed ID: 14714120
    [Abstract] [Full Text] [Related]

  • 11. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?
    Castrogiovanni P, Blardi P, De Lalla A, Dell'Erba A, Auteri A.
    Psychopharmacol Bull; 2003 Dec 01; 37(2):102-8. PubMed ID: 14566218
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB, Thase ME, EPIC 014 Study Group.
    J Psychiatr Res; 2007 Dec 01; 41(3-4):351-9. PubMed ID: 16165158
    [Abstract] [Full Text] [Related]

  • 15. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR, Mulder RT, McKenzie JM, Luty SE, Cloninger CR.
    Depress Anxiety; 2004 Dec 01; 19(3):180-6. PubMed ID: 15129420
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects.
    Grassi B, Gambini O, Scarone S.
    Pharmacopsychiatry; 1995 May 01; 28(3):93-4. PubMed ID: 7568371
    [Abstract] [Full Text] [Related]

  • 18. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 01; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 19. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M.
    J Clin Pharm Ther; 2005 Apr 01; 30(2):133-8. PubMed ID: 15811165
    [Abstract] [Full Text] [Related]

  • 20. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF, Lane RM, Zhu R, Ying Z.
    Int Clin Psychopharmacol; 1999 Sep 01; 14(5):259-75. PubMed ID: 10529069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.